Document/ExhibitDescriptionPagesSize 1: 8-K Current Report HTML 41K
5: R1 Cover HTML 48K
8: XML IDEA XML File -- Filing Summary XML 11K
6: XML XBRL Instance -- hlth-20220921_htm XML 22K
7: EXCEL IDEA Workbook of Financial Reports XLSX 8K
3: EX-101.LAB XBRL Labels -- hlth-20220921_lab XML 72K
4: EX-101.PRE XBRL Presentations -- hlth-20220921_pre XML 35K
2: EX-101.SCH XBRL Schema -- hlth-20220921 XSD 10K
9: JSON XBRL Instance as JSON Data -- MetaLinks 12± 17K
10: ZIP XBRL Zipped Folder -- 0001628945-22-000141-xbrl Zip 16K
Registrant's telephone number, including area code: (i858) i412-8151
Former name or address, if changed since last report: Not Applicable.
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
i☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
i☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
i☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
i☐ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
iCommon
Stock, par value $0.00001 per share
iHLTH
iNasdaq Global Stock Market
Indicate by check mark
whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company i☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. i☐
.
Item 5.07 Submission of Matters to a Vote of Security Holders.
The 2022 Annual
Meeting of Stockholders (the “Annual Meeting”) of Cue Health Inc. (the “Company”) was held on September 21, 2022. Present at the Annual Meeting in person or by proxy were holders of 107,417,753 shares of the Company’s common stock, representing 72.50% of the voting power of the shares of the Company’s common stock as of August 5, 2022, the record date for the Annual Meeting, and constituting a quorum for the transaction of business. The matters that were voted upon at the Annual Meeting, and the number of votes cast for, against or withheld, as well as the number of abstentions and broker non-votes as to each such matter, where applicable, are set forth below.
Each
share of common stock was entitled to one vote on each proposal.
At the Annual Meeting, the Company’s stockholders (1) elected the Company’s nominee for director and (2) ratified the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
Proposal 1 – Election of one Class I director, Joshua Ghaim, to hold office until the Company’s 2025 Annual Meeting
of Stockholders:
Votes
For
Votes Against
Abstentions
Broker Non-Votes
Joshua Ghaim
66,072,907
4,025,872
9,843,580
27,475,394.00
Proposal
2 – Ratification of the appointment of BDO USA, LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022:
Votes For
Votes Against
Abstentions
107,125,903
234,135
57,715
2
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
